Two Sigma Investments’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2M | Sell |
212,710
-140,554
| -40% | -$1.54M | ﹤0.01% | 2756 |
|
|
2025
Q4 | $4.39M | Sell |
353,264
-166,102
| -32% | -$2.21M | 0.01% | 1831 |
|
|
2025
Q3 | $7.44M | Buy |
519,366
+57,881
| +13% | +$793K | 0.01% | 1150 |
|
|
2025
Q2 | $5.66M | Buy |
461,485
+75,485
| +20% | +$1.1M | 0.01% | 1158 |
|
|
2025
Q1 | $8.49M | Sell |
386,000
-115,400
| -23% | -$2.71M | 0.02% | 826 |
|
|
2024
Q4 | $11.4M | Sell |
501,400
-170,047
| -25% | -$3.71M | 0.02% | 689 |
|
|
2024
Q3 | $12.2M | Buy |
671,447
+227,796
| +51% | +$5.28M | 0.03% | 671 |
|
|
2024
Q2 | $12.9M | Buy |
443,651
+1,035
| +0.2% | +$30.7K | 0.03% | 608 |
|
|
2024
Q1 | $15.7M | Buy |
442,616
+172,877
| +64% | +$6.91M | 0.04% | 512 |
|
|
2023
Q4 | $11.7M | Sell |
269,739
-110,122
| -29% | -$4.33M | 0.03% | 607 |
|
|
2023
Q3 | $14.5M | Buy |
379,861
+189,471
| +100% | +$7.97M | 0.04% | 465 |
|
|
2023
Q2 | $7.83M | Buy |
190,390
+131,912
| +226% | +$6.35M | 0.02% | 740 |
|
|
2023
Q1 | $3.36M | Sell |
58,478
-144,741
| -71% | -$8.16M | 0.01% | 1097 |
|
|
2022
Q4 | $11.4M | Sell |
203,219
-221,128
| -52% | -$11.3M | 0.04% | 507 |
|
|
2022
Q3 | $18M | Sell |
424,347
-48,493
| -10% | -$2.48M | 0.06% | 346 |
|
|
2022
Q2 | $25.5M | Buy |
472,840
+190,396
| +67% | +$11.4M | 0.08% | 270 |
|
|
2022
Q1 | $18.1M | Buy |
+282,444
| New | +$18.6M | 0.05% | 410 |
|
|
2021
Q3 | – | Sell |
-32,056
| Closed | -$2.19M | – | 4450 |
|
|
2021
Q2 | $2.19M | Buy |
32,056
+24,526
| +326% | +$1.73M | 0.01% | 1782 |
|
|
2021
Q1 | $520K | Buy |
+7,530
| New | +$510K | ﹤0.01% | 2892 |
|
|
2020
Q3 | – | Sell |
-4,548
| Closed | -$214K | – | 3295 |
|
|
2020
Q2 | $214K | Sell |
4,548
-54,189
| -92% | -$2.66M | ﹤0.01% | 2600 |
|
|
2020
Q1 | $2.62M | Buy |
58,737
+9,941
| +20% | +$522K | 0.02% | 823 |
|
|
2019
Q4 | $2.84M | Sell |
48,796
-65,331
| -57% | -$3.89M | 0.01% | 1321 |
|
|
2019
Q3 | $6.86M | Buy |
114,127
+6,092
| +6% | +$363K | 0.02% | 712 |
|
|
2019
Q2 | $6.03M | Buy |
+108,035
| New | +$5.56M | 0.02% | 817 |
|
|
2018
Q3 | – | Sell |
-57,510
| Closed | -$3.7M | – | 3366 |
|
|
2018
Q2 | $3.7M | Buy |
+57,510
| New | +$3.56M | 0.01% | 1196 |
|
|
2017
Q3 | – | Sell |
-16,670
| Closed | -$909K | – | 2949 |
|
|
2017
Q2 | $909K | Sell |
16,670
-209,675
| -93% | -$10M | ﹤0.01% | 1957 |
|
|
2017
Q1 | $9.54M | Sell |
226,345
-287,769
| -56% | -$12.3M | 0.03% | 628 |
|
|
2016
Q4 | $22.1M | Buy |
514,114
+262,682
| +104% | +$10.7M | 0.08% | 281 |
|
|
2016
Q3 | $10.4M | Buy |
251,432
+174,658
| +227% | +$7.32M | 0.04% | 537 |
|
|
2016
Q2 | $3.06M | Sell |
76,774
-55,200
| -42% | -$1.99M | 0.01% | 1018 |
|
|
2016
Q1 | $4.45M | Buy |
131,974
+56,850
| +76% | +$1.77M | 0.02% | 770 |
|
|
2015
Q4 | $2.55M | Sell |
75,124
-140,340
| -65% | -$4.39M | 0.01% | 973 |
|
|
2015
Q3 | $6.42M | Sell |
215,464
-73,959
| -26% | -$2.31M | 0.03% | 458 |
|
|
2015
Q2 | $7.97M | Buy |
289,423
+107,528
| +59% | +$2.87M | 0.04% | 513 |
|
|
2015
Q1 | $4.58M | Buy |
181,895
+107,975
| +146% | +$2.55M | 0.02% | 764 |
|
|
2014
Q4 | $1.64M | Buy |
+73,920
| New | +$1.5M | 0.01% | 1115 |
|
|
2014
Q3 | – | Sell |
-75,028
| Closed | -$1.44M | – | 1874 |
|
|
2014
Q2 | $1.44M | Sell |
75,028
-52,343
| -41% | -$975K | 0.01% | 1161 |
|
|
2014
Q1 | $2.39M | Buy |
+127,371
| New | +$2.46M | 0.01% | 872 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Two Sigma Investments's IART Position: Q1 2026 in Review
Two Sigma Investments reduced its Integra LifeSciences (IART) stake by 40% in Q1 2026, selling an estimated $1.54M and leaving 212,710 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2756.
Two Sigma Investments first reported a position in IART in Q1 2014 and has held it in 38 quarters since. The position peaked at $25.5M in Q2 2022. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Two Sigma Investments held 212,710 shares of Integra LifeSciences worth $2M as of Q1 2026.
- Two Sigma Investments sold 140,554 Integra LifeSciences shares in Q1 2026, an estimated $1.54M.
- Integra LifeSciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2756 holding.
- Two Sigma Investments first reported a position in Integra LifeSciences in Q1 2014 and has held it in 38 quarters since.
- Two Sigma Investments's Integra LifeSciences position peaked at $25.5M in Q2 2022.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.